TNF and inflammatory bowel disease: Thus, we evaluated the in vivo effects of RI-962 in two animal models of inflammatory diseases: TNFα-induced systemic inflammatory response syndrome (SIRS) and dextran sulfate sodium (DSS)-induced inflammatory bowel disease (IBD).